Provided by Tiger Trade Technology Pte. Ltd.

AMPLIFY WEIGHT LOSS DRUG & TREATMENT ETF

24.52
+0.26981.11%
Post-market: 23.58-0.9404-3.84%16:04 EDT
Volume:2K
Turnover:37.85K
Market Cap:5.64M
PE:- -
High:24.52
Open:24.22
Low:23.58
Close:24.25
52wk High:27.94
52wk Low:22.89
Shares:230.00K
Float Shares:230.00K
Volume Ratio:1.31
T/O Rate:0.68%
Dividend:0.41
Dividend Rate:1.68%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

1s Could Offer Unexpected Relief from Back and Knee Pain, but Doctors Urge Caution

Dow Jones
·
Oct 08

Scholar Rock Resubmits Apitegromab MAA to EMA for SMA Treatment

Reuters
·
Oct 08

Scholar Rock Holding Corporation - Anticipates Chmp Opinion on Apitegromab Maa in H1 2027

THOMSON REUTERS
·
Oct 08

Scholar Rock Resubmits Apitegromab Marketing Authorisation Application (Maa) to European Medicines Agency (Ema) for Treatment of Children and Adults with Spinal Muscular Atrophy (Sma)

THOMSON REUTERS
·
Oct 08

How to invest in healthcare stocks without picking the next Eli Lilly

Simply Wall St.
·
Oct 08

Dow Falls Over 300 Points As Treasury Yields Surge: Investor Sentiment Weakens, Fear & Greed Index Remains In ‘Neutral’ Zone

Benzinga Earnings
·
Oct 08

Eli Lilly & Co. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Oct 08

Hims & Hers Names Jon Franklin as Chief Accounting Officer

THOMSON REUTERS
·
Oct 08

Hims & Hers Names Jonathan Franklin Principal Accounting Officer as Irene Becklund Resigns Role

Reuters
·
Oct 08

Cboe data suggests bullish flow in Novo Nordisk with shares up 1.69%

TIPRANKS
·
Oct 08

Eli Lilly and Co Stock (LLY) Moved Up by 3.94% on Oct 7: Facts Behind the Movement

TradingKey
·
Oct 08

Amgen Inc Stock (AMGN) Moved Up by 3.06% on Oct 7: A Full Analysis

TradingKey
·
Oct 08

Novo Nordisk A/S Series B Stock Rises Wednesday, Outperforms Market

Dow Jones
·
Oct 08

S&P 500 Top and Bottom Performing Stocks at About 12:00 P.m. EDT

Reuters
·
Oct 08

Novo Nordisk call volume above normal and directionally bullish

TIPRANKS
·
Oct 07

European Equities Traded in US as ADRs Fall in Wednesday Trading

MT Newswires Live
·
Oct 07

Pharma Lobby Sues Trump Administration over Medicare Drug Price Cuts

Reuters
·
Oct 07

Eli Lilly is Maintained at Overweight by Morgan Stanley

Dow Jones
·
Oct 07

What Eli Lilly Stock's First Line Jaypirca Approval Means For Shareholders

Simply Wall St.
·
Oct 07

Morgan Stanley Adjusts Price Target on Eli Lilly to $1,430 From $1,419

MT Newswires Live
·
Oct 07